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Supplemental Figure 1. Lactacystin inhibits proteasome activity in octopaminergic neurons.  
Octopaminergic neurons expressing the GFP-labeled UAS-degron and incubated in 100µM lactacystin 
(45 min) show higher levels of fluorescence than cells treated in parallel with vehicle (DMSO) alone. 
Maximum fluorescence was recorded from individual cells in each nerve cord (Mann-Whitney, p < 0.05, 
6 animals per treatment, 3 separate experiments, 1 to 14 cells per animal). Box and whiskers represent 
minimum, first quartile, median (line), mean (solid grey circle), third quartile and maximum. 
 
 
Supplemental Figure 2. Pan-neuronal E1 RNAi expression decreases proteasome activity in the 
larval nerve cord. A) Flies pan-neuronally expressing the GFP-tagged UAS-degron construct show 
minimal labeling of the neuropil in the ventral nerve cord (representative image for 6 of 7 animals from 3 
experiments; 1 additional sample showed weak labeling of the neuropil).  B) Larvae co-expressing 
UAS-E1-RNAi and the UAS-degron show widespread fluorescent labeling in the neuropil 
(representative image for 5 of 6 animals from 3 experiments; 1 other sample showed weaker labeling of 
the neuropil). Posterior segments are shown in both images, with the terminus of the nerve cord 
oriented downward in each panel. Arrows in A and B indicate comparable areas. Scale bars: 50 
microns.  
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Supplemental Figure 3. E1 RNAi expression in octopaminergic neurons inhibits proteasome 
activity. Octopaminergic neurons expressing a GFP labeled UAS-degron alone (A) show lower levels 
of fluorescence than those co-expressing the UAS-degron plus a UAS-E1 RNAi transgene (B). The 
midline of the nerve cord terminus is shown in each panel. Arrowheads indicate cell clusters. Scale 
bars: 25 microns. C) Maximum fluorescence (arbitrary units or afu) was quantified from individual cells 
in each nerve cord (Mann-Whitney, p < 0.005, >3 animals per treatment, 7 to 18 cells per animal, 3 
separate experiments). Box and whiskers represent minimum, first quartile, median (line), mean (solid 
grey circle), third quartile and maximum.  
 
 
 
 
 
 
 
Supplemental Methods. For all Supplemental Experiments, flies expressing the degron transgene 
UAS-GFP CLI alone, or both UAS-GFP CLI and UAS-E1 RNAi were crossed to driver lines expressing 
either elav-GAL4 (Supplemental Figure 1) or Tdc2-GAL4 (Supplemental Figures 2 and 3). F1 progeny 
were collected as third instar larvae and larval fillets dissected in chilled HL3.1. For Supplemental 
Figure 1, the fillet was then pre treated in either 100µM lactacystin (45 min, 18°C) or vehicle alone 
(DMSO) prior to fixation. For all experiments, tissue was fixed in 4% paraformaldehyde (25 min) 
washed 3x in PBS and immersed in 70% glycerol for mounting. Confocal stacks (1024 x 1024 pixels) 
were collected on a Zeiss Pascal LSM 5 confocal microscope using a 20x/0.8 Plan-Apochromat 
objective and a pinhole size of 1 Airy unit. Identical laser intensity and gain settings were used for all 
samples and conditions in each experiment To quantify fluorescence intensity, Regions of Interest 
(ROIs) were traced around individual cells using Image J, and the maximum level of fluorescence 
(arbitrary units or “afu”) within each ROI was plotted.   	  
